These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10984368)

  • 21. Comparison of mometasone furoate administered by metered dose inhaler with beclomethasone dipropionate.
    Chervinsky P; Nelson HS; Bernstein DI; Berkowitz RA; Siegel SC
    Int J Clin Pract; 2002; 56(6):419-25. PubMed ID: 12166539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings.
    Tohda Y; Miyamoto T
    Curr Med Res Opin; 2010 Jan; 26(1):203-12. PubMed ID: 19921960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study.
    Price D; Robertson A; Bullen K; Rand C; Horne R; Staudinger H
    BMC Pulm Med; 2010 Jan; 10():1. PubMed ID: 20051135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler.
    Bousquet J; D'Urzo A; Hebert J; Barraza CH; Boulet LP; Suárez-Chacón R; Harnest U; Lundbäck B; Martinez Morales G; Nieminen MM; Nolop KB; Visser S; Lutsky BN
    Eur Respir J; 2000 Nov; 16(5):808-16. PubMed ID: 11153576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of dosing and comparative doses of mometasone furoate: a meta-analysis.
    Hart K; Weatherall M; Shirtcliffe P; Beasley R
    Respirology; 2009 Nov; 14(8):1166-72. PubMed ID: 19818054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of mometasone furoate administered via a dry powder inhaler once daily in the evening on nocturnal lung function and sleep parameters in patients with moderate persistent asthma: a randomized, double-blind, placebo-controlled pilot study.
    Krouse JH; Krouse HJ; Janisse JJ
    Clin Drug Investig; 2009; 29(1):51-8. PubMed ID: 19067474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma.
    Meltzer EO; Wenzel S
    J Asthma; 2006 Dec; 43(10):765-72. PubMed ID: 17169829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma.
    Noonan M; Leflein J; Corren J; Staudinger H
    BMC Pediatr; 2009 Jul; 9():43. PubMed ID: 19594937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.
    Sharpe M; Jarvis B
    Drugs; 2001; 61(9):1325-50. PubMed ID: 11511026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
    Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
    Bernstein DI; Berkowitz RB; Chervinsky P; Dvorin DJ; Finn AF; Gross GN; Karetzky M; Kemp JP; Laforce C; Lumry W; Mendelson LM; Nelson H; Pearlman D; Rachelefsky G; Ratner P; Repsher L; Segal AT; Selner JC; Settipane GA; Wanderer A; Cuss FM; Nolop KB; Harrison JE
    Respir Med; 1999 Sep; 93(9):603-12. PubMed ID: 10542973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM; Nathan RA; Meltzer EO; Ortega HG; Yancey SW; Schoaf L; Dorinsky PM
    Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mometasone furoate: an effective anti-inflammatory with a well-defined safety and tolerability profile in the treatment of asthma.
    Bousquet J
    Int J Clin Pract; 2009 May; 63(5):806-19. PubMed ID: 19392928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled trial of twice daily triamcinolone oral inhaler in patients with mild-to-moderate asthma.
    Ramsdell JW; Fish L; Graft D; Higgins N; Kavuru M; Pleskow W; Banerji D
    Ann Allergy Asthma Immunol; 1998 May; 80(5):385-90. PubMed ID: 9609607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
    J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study.
    LaForce C; Alexander M; Deckelmann R; Fabbri LM; Aisanov Z; Cameron R; Owen R; Higgins M
    Allergy; 2008 Jan; 63(1):103-11. PubMed ID: 18053019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids.
    Weinstein SF; Corren J; Murphy K; Nolte H; White M;
    Allergy Asthma Proc; 2010; 31(4):280-9. PubMed ID: 20687982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.